STRATUS Focus on Dermatological and Wound Care Markets Kendall, FL October 10,2003

STRATUS PHARMACEUTICALS INC., a minority owned pharmaceutical distributor and manufacturer of dermatology and wound care specialty products with an emphasis in cost containment announced today that, in continuing with our commitment to the wound care industry, we have established a web site link that will offer Health Care Providers information and answers regarding wound care questions.

Click on this link to ask the wound care specialist

This link will connect the Health Care Provider with Stratus’s wound care specialist, Dr. Oscar Barreto, DPM, RN,FACFAS,CWS. Dr. Barreto is a professor of Foot Surgery and Director of the Residency Program at Larkin General Hospital in Miami. In order to access this service please go into the Stratus web-site www.stratus pharmaceuticals.com and connect with the Press Release section.

Mr. Alberto Hoyo, president and chief executive officer commented “our commitment to wound care continues, and we are very proud to offer this service to Health Care Providers”. In addition, Mr. Hoyo, added “our product development efforts will be pursued both independently or in collaboration with corporate partners, and includes marketed drugs as well as drugs under development”. We will selectively consider acquisition and cross-licensing opportunities of other technologies or products consistent with our objectives in these two clinical areas.

The Company’s dermatology program has near-term emphasis on the treatment of hyperpigmentation, eczema, dermatitis, hyperhidrosis, bacteria and fungus infections with applications in the Podiatry Market. The Wound Care program concentrates in products for the debridement and healing of wounds with three products with unique dosage form sizes and another product in the pipeline. Peviderm, a patented wound care cleanser and healing product, helps in the control of wound infections and is an integral part of our Wound Care Program; Peviderm has just recently received an additional patent.

On December 17, 2002 Stratus completed its reorganization plan in a record time of 10 months during which there were no disruption in customer service or manufacturing and quality of the products. Management is engaged in the continued growth of the company. The financial position of Stratus is a solid one that will increase as the years progresses. Mr. Hoyo said that the future of Stratus is brighter than a year ago now that all legal battles have been settle.